NCCN Guidelines Panel: Non-Hodgkin's Lymphomas On behalf of Millennium Pharmaceuticals, Inc., I respectfully request the NCCN Non- Hodgkin's Lymphomas Guidelines Panel to review the enclosed data on the use of VELCADE